Cipla beats quarterly profit view on strong demand
Cipla reports a fourth-quarter profit. File | Photo Credit: Reuters Cipla, India’s third-biggest drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday (May 13, 2025), helped by strong demand for its drugs used to treat chronic conditions, especially respiratory illnesses. The company’s consolidated net profit came in at ₹12.22 billion ($143.5 million) […]
Continue Reading
